Cargando…
Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs
The Human Papillomavirus (HPV) vaccines have been widely introduced in the national immunization programs in most of the medium and high income countries following endorsement from national and international advisory bodies. HPV vaccine is unique and its introduction is challenging in many ways – it...
Autores principales: | Basu, Partha, Banerjee, Dipanwita, Singh, Priyanka, Bhattacharya, Chandrani, Biswas, Jaydip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889021/ https://www.ncbi.nlm.nih.gov/pubmed/24455618 http://dx.doi.org/10.4103/2278-330X.119877 |
Ejemplares similares
-
Is human papillomavirus vaccination likely to be a useful strategy in India?
por: Gupta, Sudeep, et al.
Publicado: (2013) -
Does HPV vaccination prevent cervical cancer?
por: Miller, Anthony B.
Publicado: (2013) -
Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16
por: Ki, Eun Young, et al.
Publicado: (2016) -
Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017) -
Triage Value of Cervical Exfoliated Cell DNA Ploidy Analysis in Cervical High-Risk Human Papillomavirus–Positive Women
por: Chu, Boliang, et al.
Publicado: (2023)